JAFRA DAILY description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

JAFRA DAILY

JAFRA COSMETICS INTERNATIONAL

JAFRA DAILY FLORAL MIST




FULL PRESCRIBING INFORMATION

Active ingredient

ACTIVE INGREDIENT



Purpose

PURPOSE

ANTIPERSPIRANT

INACTIVE INGREDIENTS: WATER/AQUA, CYCLOMETHICONE, PPG-15 STEARYL ETHER, STEARETH-2, CETETH-20, FARNESOL, AVENA SATIVA (OAT) KERNEL EXTRACT, FRAGRANCE/PARFUM, ISOPROPYL PALMITATE, TRICONTANYL PVP, BUTYLENE GLYCOL, PHENOXYETHANOL, METHYLPARABEN, ETHYLPARABEN, PROPYLPARABEN, BUTYLPARABEN.

Uses

USES

  • REDUCES UNDERARM WETNESS

DIRECTIONS

  • APPLY TO UNDERARMS ONLY

WARNINGS

  • DO NOT USE ON BROKEN SKIN.
  • STOP USE IF RASH OR IRRITATION OCCURS.

KEEP OUT OF REACH OF CHILDREN.

JAFRA








JAFRA DAILYJAFRA DAILY
  • ASK A DOCTOR BEFORE USE IF YOU HAVE KIDNEY DISEASE.

JAFRA DAILY

ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY LOTION

Product Information

Product Type Human otc drug label Item Code (Source) NDC:68828-052
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
Aluminum Zirconium Tetrachlorohydrex GLY Aluminum Zirconium Tetrachlorohydrex GLY 15 g

Inactive Ingredients

Ingredient Name Strength
water
cyclomethicone
PPG-15 Stearyl Ether
STEARETH-2
SORBITAN SESQUIOLEATE
CETETH-20
Farnesol
OAT
ISOPROPYL PALMITATE
POVIDONE K30
BUTYLENE GLYCOL
PHENOXYETHANOL
METHYLPARABEN
ETHYLPARABEN
PROPYLPARABEN
BUTYLPARABEN

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:68828-052-32 60 in 1 BOTTLE
2 NDC:68828-052-52 1 in 1 BOX

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part350 2012-04-24


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.